{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:30:13Z","timestamp":1787617813417,"version":"build-2736575974"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13555-022-00854-3","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T21:53:39Z","timestamp":1669758819000},"page":"115-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review"],"prefix":"10.1007","volume":"13","author":[{"given":"Sophia","family":"Ly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Manjaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-5617","authenticated-orcid":false,"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"854_CR1","doi-asserted-by":"crossref","unstructured":"Hoefel I da R, Weber MB, Manzoni APD, Lovato BH, Bonamigo RR. striae gravidarum, acne, facial spots, and hair disorders: risk factors in a study with 1284 puerperal patients. J Preg. Hindawi; 2020;2020.","DOI":"10.1155\/2020\/8036109"},{"key":"854_CR2","doi-asserted-by":"crossref","unstructured":"Ayanlowo OO, Otrofanowie E, Shorunmu TO, Adegbola O. Pregnancy dermatoses: a study of patients attending antenatal clinics at two tertiary care centers in southwest Nigeria. Haraka Publishing Platform; 2020.","DOI":"10.11604\/pamj-cm.2020.3.156.23602"},{"key":"854_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2340\/00015555-1594","volume":"94","author":"B Dr\u00e9no","year":"2014","unstructured":"Dr\u00e9no B, Blouin E, Moyse D, Bodokh I, Knol AC, Khammari A. Acne in pregnant women: a French survey. Acta Derm Venereol. 2014;94:82\u20133.","journal-title":"Acta Derm Venereol"},{"key":"854_CR4","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/jdv.13667","volume":"30","author":"C-C Yang","year":"2016","unstructured":"Yang C-C, Huang Y-T, Yu C-H, Wu M-C, Hsu C-C, Chen W. Inflammatory facial acne during uncomplicated pregnancy and post-partum in adult women: a preliminary hospital-based prospective observational study of 35 cases from Taiwan. J Eur Acad Dermatol Venereol England. 2016;30:1787\u20139.","journal-title":"J Eur Acad Dermatol Venereol England"},{"key":"854_CR5","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/ijd.14999","volume":"59","author":"\u00d6 Kutlu","year":"2020","unstructured":"Kutlu \u00d6, Karada\u011f AS, \u00dcnal E, Kelek\u00e7i KH, Yal\u00e7\u0131nkaya \u0130yidal A, Topalo\u011flu Demir F, et al. Acne in pregnancy: a prospective multicenter, cross-sectional study of 295 patients in Turkey. Int J Dermatol England. 2020;59:1098\u2013105.","journal-title":"Int J Dermatol England"},{"key":"854_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/dth.12077","volume":"26","author":"R Pugashetti","year":"2013","unstructured":"Pugashetti R, Shinkai K. Treatment of acne vulgaris in pregnant patients. Dermatol Ther [Internet]. 2013;26:302\u201311. https:\/\/doi.org\/10.1111\/dth.12077.","journal-title":"Dermatol Ther [Internet]."},{"key":"854_CR7","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/S0140-6736(18)30311-8","volume":"391","author":"J Stephenson","year":"2018","unstructured":"Stephenson J, Heslehurst N, Hall J, Schoenaker DAJM, Hutchinson J, Cade JE, et al. Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health. Lancet. 2018;391:1830\u201341.","journal-title":"Lancet"},{"key":"854_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijwd.2015.12.005","volume":"2","author":"CM Blattner","year":"2016","unstructured":"Blattner CM, Danesh M, Safaee M, Murase JE. Understanding the new FDA pregnancy and lactation labeling rules. Int J Womens Dermatol. 2016;2:5\u20137.","journal-title":"Int J Womens Dermatol."},{"key":"854_CR9","volume-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","author":"GG Briggs","year":"2012","unstructured":"Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Philadelphia: Lippincott Williams & Wilkins; 2012."},{"key":"854_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.clindermatol.2016.02.013","volume":"34","author":"E Wilmer","year":"2016","unstructured":"Wilmer E, Chai S, Kroumpouzos G. Drug safety: Pregnancy rating classifications and controversies. Clin Dermatol [Internet]. 2016;34:401\u20139.","journal-title":"Clin Dermatol [Internet]."},{"key":"854_CR11","doi-asserted-by":"crossref","unstructured":"Chien AL, Qi J, Rainer B, Sachs DL, Helfrich YR. Treatment of acne in pregnancy. J Am Board Fam Med [Internet]. American Board of Family Medicine; 2016 [cited 2022 Aug 8];29:254\u201362. https:\/\/www.jabfm.org\/content\/29\/2\/254","DOI":"10.3122\/jabfm.2016.02.150165"},{"key":"854_CR12","unstructured":"Drugs and Lactation Database (LactMed) [Internet] [Internet]. Bethesda (MD): National Library of Medicine (US); https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501922\/"},{"key":"854_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1542\/peds.108.3.776","volume":"108","author":"American Academy of Pediatrics Committee on Drugs","year":"2001","unstructured":"American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776\u201389.","journal-title":"Pediatrics"},{"key":"854_CR14","volume-title":"Hale\u2019s medications & mothers\u2019 milk 2023: a manual of lactational pharmacology","author":"TW Hale","year":"2022","unstructured":"Hale TW, Krutsch K. Hale\u2019s medications & mothers\u2019 milk 2023: a manual of lactational pharmacology. Berlin: Springer; 2022."},{"key":"854_CR15","doi-asserted-by":"publisher","first-page":"417.e1","DOI":"10.1016\/j.jaad.2013.09.009","volume":"70","author":"DC Butler","year":"2014","unstructured":"Butler DC, Heller MM, Murase JE. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation. J Am Acad Dermatol [Internet]. 2014;70:417.e1-417.e10.","journal-title":"J Am Acad Dermatol [Internet]."},{"key":"854_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1600-0625.1992.tb00185.x","volume":"1","author":"U T\u00e4uber","year":"1992","unstructured":"T\u00e4uber U, Weiss C, Matthes H. Percutaneous absorption of azelaic acid in humans. Exp Dermatol. 1992;1:176\u20139.","journal-title":"Exp Dermatol"},{"key":"854_CR17","doi-asserted-by":"publisher","first-page":"401.e1","DOI":"10.1016\/j.jaad.2013.09.010","volume":"70","author":"JE Murase","year":"2014","unstructured":"Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Am Acad Dermatol [Internet]. 2014;70:401.e1-401.e14.","journal-title":"J Am Acad Dermatol [Internet]."},{"key":"854_CR18","first-page":"964","volume":"14","author":"BC Schulte","year":"2015","unstructured":"Schulte BC, Wu W, Rosen T. Azelaic acid: evidence-based update on mechanism of action and clinical application. J Drugs Dermatol. 2015;14:964\u20138.","journal-title":"J Drugs Dermatol"},{"key":"854_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40257-013-0049-1","volume":"15","author":"NC Yin","year":"2014","unstructured":"Yin NC, McMichael AJ. Acne in patients with skin of color: practical management. Am J Clin Dermatol [Internet]. 2014;15:7\u201316.","journal-title":"Am J Clin Dermatol [Internet]."},{"key":"854_CR20","first-page":"586","volume":"10","author":"LH Kircik","year":"2011","unstructured":"Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10:586\u201390.","journal-title":"J Drugs Dermatol"},{"key":"854_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40257-013-0041-9","volume":"14","author":"FM Meredith","year":"2013","unstructured":"Meredith FM, Ormerod AD. The management of acne vulgaris in pregnancy. Am J Clin Dermatol [Internet]. 2013;14:351\u20138.","journal-title":"Am J Clin Dermatol [Internet]."},{"key":"854_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s40265-013-0060-0","volume":"73","author":"YL Kong","year":"2013","unstructured":"Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. Drugs [Internet]. 2013;73:779\u201387.","journal-title":"Drugs [Internet]."},{"key":"854_CR23","unstructured":"ACOG. Skin Conditions During Pregnancy [Internet]. American College of Obstetricians and Gynecologists. 2022 [cited 2022 Aug 25]. https:\/\/www.acog.org\/womens-health\/faqs\/skin-conditions-during-pregnancy."},{"key":"854_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/jdv.12061","volume":"27","author":"B Dr\u00e9no","year":"2013","unstructured":"Dr\u00e9no B, Layton A, Zouboulis CC, L\u00f3pez-Estebaranz JL, Zalewska-Janowska A, Bagatin E, et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol [Internet]. 2013;27:1063\u201370. https:\/\/doi.org\/10.1111\/jdv.12061.","journal-title":"J Eur Acad Dermatol Venereol [Internet]."},{"key":"854_CR25","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1517\/14656560903277228","volume":"10","author":"M Sagransky","year":"2009","unstructured":"Sagransky M, Yentzer BA, Feldman SR. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert Opin Pharmacother. 2009;10:2555\u201362.","journal-title":"Expert Opin Pharmacother"},{"key":"854_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1529-8019.2012.01493.x","volume":"25","author":"CR Drucker","year":"2012","unstructured":"Drucker CR. Update on topical antibiotics in dermatology. Dermatol Ther. 2012;25:6\u201311.","journal-title":"Dermatol Ther"},{"key":"854_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1529-8019.2012.01497.x","volume":"25","author":"RM Mays","year":"2012","unstructured":"Mays RM, Gordon RA, Wilson JM, Silapunt S. New antibiotic therapies for acne and rosacea. Dermatol Ther. 2012;25:23\u201337.","journal-title":"Dermatol Ther"},{"key":"854_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","volume":"56","author":"JS Strauss","year":"2007","unstructured":"Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56:651\u201363.","journal-title":"J Am Acad Dermatol"},{"key":"854_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0190-9622(81)70004-5","volume":"4","author":"S Nacht","year":"1981","unstructured":"Nacht S, Yeung D, Beasley JN, Anjo MD, Maibach HI. Benzoyl peroxide: percutaneous penetration and metabolic disposition. J Am Acad Dermatol. 1981;4:31\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"854_CR30","first-page":"20","volume":"57","author":"K Graupe","year":"1996","unstructured":"Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis. 1996;57:20\u201335.","journal-title":"Cutis"},{"key":"854_CR31","unstructured":"del Rosso JQ. The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. J Clin Aesthet Dermatol. 2009. p. 26\u20139."},{"key":"854_CR32","first-page":"128","volume":"96","author":"S Silapunt","year":"2015","unstructured":"Silapunt S. The use of sodium sulfacetamide in dermatology. Cutis. 2015;96:128\u201330.","journal-title":"Cutis"},{"key":"854_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.det.2006.01.001","volume":"24","author":"SA Leachman","year":"2006","unstructured":"Leachman SA, Reed BR. The use of dermatologic drugs in pregnancy and lactation. Dermatol Clin. 2006;24:167\u201397.","journal-title":"Dermatol Clin"},{"key":"854_CR34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/B978-1-4377-2003-7.00064-9","volume-title":"Dermatologic drugs during pregnancy and lactation. Comprehensive dermatologic drug therapy","author":"KB Lee","year":"2013","unstructured":"Lee KB, Leachman SA. Dermatologic drugs during pregnancy and lactation. Comprehensive dermatologic drug therapy. Oxford: Elsevier; 2013. p. 718\u201329."},{"key":"854_CR35","first-page":"427","volume":"3","author":"AK Gupta","year":"2004","unstructured":"Gupta AK, Nicol K. The use of sulfur in dermatology. J Drugs Dermatol. 2004;3:427\u201331.","journal-title":"J Drugs Dermatol"},{"key":"854_CR36","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","volume":"37","author":"DP Lookingbill","year":"1997","unstructured":"Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ, et al. Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol. 1997;37:590\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"854_CR37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/(SICI)1099-081X(199812)19:9<563::AID-BDD134>3.0.CO;2-E","volume":"19","author":"EJ van Hoogdalem","year":"1998","unstructured":"van Hoogdalem EJ, Baven TL, Spiegel-Melsen I, Terpstra IJ. Transdermal absorption of clindamycin and tretinoin from topically applied anti-acne formulations in man. Biopharm Drug Dispos. 1998;19:563\u20139.","journal-title":"Biopharm Drug Dispos"},{"key":"854_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/archderm.1986.01660170113031","volume":"122","author":"MF Parry","year":"1986","unstructured":"Parry MF, Rha CK. Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol. 1986;122:583\u20134.","journal-title":"Arch Dermatol"},{"key":"854_CR39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0190-9622(86)70153-9","volume":"15","author":"RJ Siegle","year":"1986","unstructured":"Siegle RJ, Fekety R, Sarbone PD, Finch RN, Deery HG, Voorhees JJ. Effects of topical clindamycin on intestinal microflora in patients with acne. J Am Acad Dermatol. 1986;15:180\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"854_CR40","unstructured":"Clindamycin [Internet]. National Library of Medicine (US), Bethesda (MD); 2006. http:\/\/europepmc.org\/abstract\/MED\/30000267"},{"key":"854_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/09546634.2016.1214234","volume":"28","author":"BA Austin","year":"2017","unstructured":"Austin BA, Fleischer ABJ. The extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin. J Dermatol Treat. 2017;28:145\u20138.","journal-title":"J Dermatol Treat"},{"key":"854_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2133.1989.tb01399.x","volume":"121","author":"EA Eady","year":"1989","unstructured":"Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol. 1989;121:51\u20137.","journal-title":"Br J Dermatol"},{"key":"854_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12895-020-00108-9","volume":"20","author":"E Alkhawaja","year":"2020","unstructured":"Alkhawaja E, Hammadi S, Abdelmalek M, Mahasneh N, Alkhawaja B, Abdelmalek SM. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study. BMC Dermatol [Internet]. 2020;20:17. https:\/\/doi.org\/10.1186\/s12895-020-00108-9.","journal-title":"BMC Dermatol [Internet]."},{"key":"854_CR44","unstructured":"Allergan. ACZONE (dapsone) [package insert]. U.S. Food and Drug Administration website. 2018."},{"key":"854_CR45","unstructured":"Dapsone. Drugs and Lactation Database (LactMed). Bethesda: National Library of Medicine (US); 2018."},{"key":"854_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jaad.2012.09.034","volume":"68","author":"KH Tyler","year":"2013","unstructured":"Tyler KH, Zirwas MJ. Pregnancy and dermatologic therapy. J Am Acad Dermatol. 2013;68:663\u201371.","journal-title":"J Am Acad Dermatol"},{"key":"854_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijwd.2017.01.005","volume":"3","author":"MK Trivedi","year":"2017","unstructured":"Trivedi MK, Kroumpouzos G, Murase JE. A review of the safety of cosmetic procedures during pregnancy and lactation. Int J Womens Dermatol [Internet]. 2017;3:6\u201310.","journal-title":"Int J Womens Dermatol [Internet]."},{"key":"854_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s13555-017-0185-2","volume":"7","author":"J Leyden","year":"2017","unstructured":"Leyden J, Stein-Gold L, Weiss J. Why topical retinoids are mainstay of therapy for acne. Dermatol Ther (Heidelb). 2017;7:293\u2013304.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"854_CR49","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.13776","volume":"30","author":"A Nast","year":"2016","unstructured":"Nast A, Dr\u00e9no B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne\u2014update 2016\u2014short version. J Eur Acad Dermatol Venereol [Internet]. 2016;30:1261\u20138. https:\/\/doi.org\/10.1111\/jdv.13776.","journal-title":"J Eur Acad Dermatol Venereol [Internet]."},{"key":"854_CR50","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1152\/physrev.2000.80.3.1021","volume":"80","author":"SA Ross","year":"2000","unstructured":"Ross SA, McCaffery PJ, Drager UC, de Luca LM. Retinoids in embryonal development. Physiol Rev [Internet]. 2000;80:1021\u201354. https:\/\/doi.org\/10.1152\/physrev.2000.80.3.1021.","journal-title":"Physiol Rev [Internet]."},{"key":"854_CR51","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0387-7604(00)00104-2","volume":"22","author":"D Selcen","year":"2000","unstructured":"Selcen D, Seidman S, Nigro MA. Otocerebral anomalies associated with topical tretinoin use. Brain Dev. 2000;22:218\u201320.","journal-title":"Brain Dev"},{"key":"854_CR52","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(05)63390-9","volume":"350","author":"E Autret","year":"1997","unstructured":"Autret E, Berjot M, Jonville-B\u00e9ra A-P, Aubry MC, Moraine C. Anophthalmia and agenesis of optic chiasma associated with adapalene gel in early pregnancy. Lancet. 1997;350:339.","journal-title":"Lancet"},{"key":"854_CR53","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1177\/0091270011429566","volume":"52","author":"A Panchaud","year":"2012","unstructured":"Panchaud A, Csajka C, Merlob P, Schaefer C, Berlin M, de Santis M, et al. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol. 2012;52:1844\u201351.","journal-title":"J Clin Pharmacol"},{"key":"854_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ajmg.a.30744","volume":"136","author":"KD Loureiro","year":"2005","unstructured":"Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, et al. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A. 2005;136:117\u201321.","journal-title":"Am J Med Genet A"},{"key":"854_CR55","first-page":"E59","volume":"13","author":"G Han","year":"2020","unstructured":"Han G, Wu JJ, del Rosso JQ. Use of topical tazarotene for the treatment of acne vulgaris in pregnancy: a literature review. J Clin Aesthet Dermatol. 2020;13:E59-65.","journal-title":"J Clin Aesthet Dermatol"},{"key":"854_CR56","unstructured":"Galderma. AKLIEF (trifarotene) [package insert]. U.S. Food and Drug Administration website. 2019."},{"key":"854_CR57","unstructured":"Drugs and Lactation Database (LactMed). Tretinoin. Bethesda: National Library of Medicine (US); 2021."},{"key":"854_CR58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","volume":"156","author":"A Hebert","year":"2020","unstructured":"Hebert A, Thiboutot D, Stein Gold L, Cartwright M, Gerloni M, Fragasso E, et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol [Internet]. 2020;156:621\u201330. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0465.","journal-title":"JAMA Dermatol [Internet]."},{"key":"854_CR59","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamadermatol.2020.0464","volume":"156","author":"JS Barbieri","year":"2020","unstructured":"Barbieri JS. A new class of topical acne treatment addressing the hormonal pathogenesis of acne. JAMA Dermatol [Internet]. 2020;156:619\u201320. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0464.","journal-title":"JAMA Dermatol [Internet]."},{"key":"854_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s13555-020-00481-w","volume":"11","author":"JJ Han","year":"2021","unstructured":"Han JJ, Faletsky A, Barbieri JS, Mostaghimi A. New acne therapies and updates on use of spironolactone and isotretinoin: a narrative review. Dermatol Ther (Heidelb). 2021;11:79\u201391.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"854_CR61","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1177\/1060028021992053","volume":"55","author":"J Kalabalik-Hoganson","year":"2021","unstructured":"Kalabalik-Hoganson J, Frey KM, Ozdener-Poyraz AE, Slugocki M. Clascoterone: a novel topical androgen receptor inhibitor for the treatment of acne. Ann Pharmacother. 2021;55:1290\u20136.","journal-title":"Ann Pharmacother"},{"key":"854_CR62","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/der2.95","volume":"2","author":"M Horissian","year":"2021","unstructured":"Horissian M, Zaenglein AL. New medications for the treatment of acne. Dermatol Rev [Internet]. 2021;2:311\u201320. https:\/\/doi.org\/10.1002\/der2.95.","journal-title":"Dermatol Rev [Internet]."},{"key":"854_CR63","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1001\/jama.2021.17633","volume":"326","author":"DZ Eichenfield","year":"2021","unstructured":"Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. JAMA [Internet]. 2021;326:2055\u201367. https:\/\/doi.org\/10.1001\/jama.2021.17633.","journal-title":"JAMA [Internet]."},{"key":"854_CR64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijwd.2017.06.001","volume":"3","author":"SZ Awan","year":"2017","unstructured":"Awan SZ, Lu J. Management of severe acne during pregnancy: a case report and review of the literature. Int J Womens Dermatol [Internet]. 2017;3:145.","journal-title":"Int J Womens Dermatol [Internet]."},{"key":"854_CR65","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","volume":"379","author":"HC Williams","year":"2012","unstructured":"Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379:361\u201372.","journal-title":"Lancet"},{"key":"854_CR66","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol [Internet]. 2016;74:945-973.e33.","journal-title":"J Am Acad Dermatol [Internet]."},{"key":"854_CR67","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1111\/bcp.14118","volume":"85","author":"S Daniel","year":"2019","unstructured":"Daniel S, Doron M, Fishman B, Koren G, Lunenfeld E, Levy A. The safety of amoxicillin and clavulanic acid use during the first trimester of pregnancy. Br J Clin Pharmacol. 2019;85:2856\u201363.","journal-title":"Br J Clin Pharmacol"},{"key":"854_CR68","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/EDE.0b013e318258cb05","volume":"23","author":"KJ Lin","year":"2012","unstructured":"Lin KJ, Mitchell AA, Yau W-P, Louik C, Hern\u00e1ndez-D\u00edaz S. Maternal exposure to amoxicillin and the risk of oral clefts. Epidemiology. 2012;23:699\u2013705.","journal-title":"Epidemiology"},{"key":"854_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n107","volume":"372","author":"NW Andersson","year":"2021","unstructured":"Andersson NW, Olsen RH, Andersen JT. Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study. BMJ. 2021;372: n107.","journal-title":"BMJ"},{"key":"854_CR70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.reprotox.2005.01.010","volume":"20","author":"BAJ K\u00e4ll\u00e9n","year":"2005","unstructured":"K\u00e4ll\u00e9n BAJ, Otterblad Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol. 2005;20:209\u201314.","journal-title":"Reprod Toxicol"},{"key":"854_CR71","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1128\/AAC.12.5.630","volume":"12","author":"WM McCormack","year":"1977","unstructured":"McCormack WM, George H, Donner A, Kodgis LF, Alpert S, Lowe EW, et al. Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother. 1977;12:630\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"854_CR72","unstructured":"Erythromycin. Drugs and lactation database (LactMed) [Internet]. Bethesda: National Library of Medicine (US); 2019."},{"key":"854_CR73","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00431-018-3287-7","volume":"178","author":"M Abdellatif","year":"2019","unstructured":"Abdellatif M, Ghozy S, Kamel MG, Elawady SS, Ghorab MME, Attia AW, et al. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Eur J Pediatr. 2019;178:301\u201314.","journal-title":"Eur J Pediatr"},{"key":"854_CR74","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13052-019-0613-2","volume":"45","author":"HH Almaramhy","year":"2019","unstructured":"Almaramhy HH, Al-Zalabani AH. The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Ital J Pediatr. 2019;45:20.","journal-title":"Ital J Pediatr"},{"key":"854_CR75","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1908","volume":"348","author":"M Lund","year":"2014","unstructured":"Lund M, Pasternak B, Davidsen RB, Feenstra B, Krogh C, Diaz LJ, et al. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study. BMJ. 2014;348: g1908.","journal-title":"BMJ"},{"key":"854_CR76","first-page":"669","volume":"69","author":"H Stang","year":"1986","unstructured":"Stang H. Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn Med. 1986;69:669\u2013670682.","journal-title":"Minn Med"},{"key":"854_CR77","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/0036554021000027010","volume":"35","author":"HT S\u00f8rensen","year":"2003","unstructured":"S\u00f8rensen HT, Skriver MV, Pedersen L, Larsen H, Ebbesen F, Sch\u00f8nheyder HC. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis. 2003;35:104\u20136.","journal-title":"Scand J Infect Dis"},{"key":"854_CR78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.29252\/wjps.8.2.127","volume":"8","author":"S Kardeh","year":"2019","unstructured":"Kardeh S, Saki N, Jowkar F, Kardeh B, Moein SA, Khorraminejad-Shirazi MH. Efficacy of azithromycin in treatment of acne vulgaris: a mini review. World J Plast Surg. 2019;8:127\u201334.","journal-title":"World J Plast Surg"},{"key":"854_CR79","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0002-9378(16)33336-1","volume":"124","author":"AJ Weinstein","year":"1976","unstructured":"Weinstein AJ, Gibbs RS, Gallagher M. Placental transfer of clindamycin and gentamicin in term pregnancy. Am J Obstet Gynecol. 1976;124:688\u201391.","journal-title":"Am J Obstet Gynecol"},{"key":"854_CR80","doi-asserted-by":"crossref","unstructured":"Gurwith MJ, Rabin HR, Love K. Diarrhea associated with clindamycin and ampicillin therapy: preliminary results of a cooperative study. J Infect Dis; 1977;135(Suppl):S104\u201310.","DOI":"10.1093\/infdis\/135.Supplement.S104"},{"key":"854_CR81","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1542\/peds.66.6.1030b","volume":"66","author":"CF Mann","year":"1980","unstructured":"Mann CF. Clindamycin and breast-feeding. Pediatrics. 1980;66:1030\u20131.","journal-title":"Pediatrics"},{"key":"854_CR82","first-page":"397","volume":"23","author":"A Hern\u00e1ndez Ceruelos","year":"2019","unstructured":"Hern\u00e1ndez Ceruelos A, Romero-Quezada LC, Ruvalcaba Ledezma JC, L\u00f3pez CL. Therapeutic uses of metronidazole and its side effects: an update. Eur Rev Med Pharmacol Sci. 2019;23:397\u2013401.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"854_CR83","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40257-020-00560-w","volume":"22","author":"DJ Patel","year":"2021","unstructured":"Patel DJ, Bhatia N. Oral antibiotics for acne. Am J Clin Dermatol. 2021;22:193\u2013204.","journal-title":"Am J Clin Dermatol"},{"key":"854_CR84","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/jama.1981.03320040015021","volume":"246","author":"H Jick","year":"1981","unstructured":"Jick H, Holmes LB, Hunter JR, Madsen S, Stergachis A. First-trimester drug use and congenital disorders. JAMA. 1981;246:343\u20136.","journal-title":"JAMA"},{"key":"854_CR85","first-page":"135","volume":"26","author":"RE Wenk","year":"1981","unstructured":"Wenk RE, Gebhardt FC, Bhagavan BS, Lustgarten JA, McCarthy EF. Tetracycline-associated fatty liver of pregnancy, including possible pregnancy risk after chronic dermatologic use of tetracycline. J Reprod Med. 1981;26:135\u201341.","journal-title":"J Reprod Med"},{"key":"854_CR86","unstructured":"Doxycycline. Drugs and lactation database (LactMed). Bethesda: National Library of Medicine (US); 2021."},{"key":"854_CR87","unstructured":"Tetracycline. Drugs and lactation database (LactMed). Bethesda: National Library of Medicine (US); 2021."},{"key":"854_CR88","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1365-4362.2002.01464.x","volume":"41","author":"EK Hale","year":"2002","unstructured":"Hale EK, Pomeranz MK. Dermatologic agents during pregnancy and lactation: an update and clinical review. Int J Dermatol. 2002;41:197\u2013203.","journal-title":"Int J Dermatol"},{"key":"854_CR89","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/archderm.1985.01660030139039","volume":"121","author":"RS Basler","year":"1985","unstructured":"Basler RS, Lynch PJ. Black galactorrhea as a consequence of minocycline and phenothiazine therapy. Arch Dermatol. 1985;121:417\u20138.","journal-title":"Arch Dermatol"},{"key":"854_CR90","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1046\/j.1365-2133.1996.134869.x","volume":"134","author":"MJ Hunt","year":"1996","unstructured":"Hunt MJ, Salisbury EL, Grace J, Armati R. Black breast milk due to minocycline therapy. Br J Dermatol. 1996;134:943\u20134.","journal-title":"Br J Dermatol"},{"key":"854_CR91","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","volume":"43","author":"G Bandoli","year":"2017","unstructured":"Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am. 2017;43:489\u2013502.","journal-title":"Rheum Dis Clin North Am"},{"key":"854_CR92","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","volume":"62","author":"L Park-Wyllie","year":"2000","unstructured":"Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385\u201392.","journal-title":"Teratology"},{"key":"854_CR93","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jaad.2020.12.071","volume":"84","author":"V Garg","year":"2021","unstructured":"Garg V, Choi JK, James WD, Barbieri JS. Long-term use of spironolactone for acne in women: a case series of 403 patients. J Am Acad Dermatol. 2021;84:1348\u201355.","journal-title":"J Am Acad Dermatol"},{"key":"854_CR94","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jaad.2018.10.023","volume":"80","author":"W Liszewski","year":"2019","unstructured":"Liszewski W, Boull C. Lack of evidence for feminization of males exposed to spironolactone in utero: a systematic review. J Am Acad Dermatol [Internet]. 2019;80:1147\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2018.10.023.","journal-title":"J Am Acad Dermatol [Internet]."},{"key":"854_CR95","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.ekir.2022.05.006","volume":"7","author":"MFC de Jong","year":"2022","unstructured":"de Jong MFC, Riphagen IJ, Kootstra-Ros JE, Groenewout M. Potassium and magnesium in breast milk of a woman with gitelman syndrome. Kidney Int Rep. 2022;7:1720\u20131.","journal-title":"Kidney Int Rep"},{"key":"854_CR96","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/trgh.2017.0044","volume":"3","author":"T Reisman","year":"2018","unstructured":"Reisman T, Goldstein Z. Case report: induced lactation in a transgender woman. Transgend Health. 2018;3:24\u20136.","journal-title":"Transgend Health"},{"key":"854_CR97","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/jps.2600660841","volume":"66","author":"DL Phelps","year":"1977","unstructured":"Phelps DL, Karim A. Spironolactone: relationship between concentrations of dethioacetylated metabolite in human serum and milk. J Pharm Sci. 1977;66:1203.","journal-title":"J Pharm Sci"},{"key":"854_CR98","first-page":"251","volume":"50","author":"DC Cominos","year":"1976","unstructured":"Cominos DC, van der Walt A, van Rooyen AJ. Suppression of postpartum lactation with furosemide. S Afr Med J. 1976;50:251\u20132.","journal-title":"S Afr Med J"},{"key":"854_CR99","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/JCAS.JCAS_226_20","volume":"15","author":"AM Garg","year":"2022","unstructured":"Garg AM, Mysore V. Dermatologic and cosmetic procedures in pregnancy. J Cutan Aesthet Surg. 2022;15:108\u201317.","journal-title":"J Cutan Aesthet Surg"},{"key":"854_CR100","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/archdermatol.2011.96","volume":"147","author":"JA Zeichner","year":"2011","unstructured":"Zeichner JA. Narrowband UV-B phototherapy for the treatment of acne vulgaris during pregnancy. Arch Dermatol [Internet]. 2011;147:537\u20139. https:\/\/doi.org\/10.1001\/archdermatol.2011.96.","journal-title":"Arch Dermatol [Internet]."},{"key":"854_CR101","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10103-011-0895-0","volume":"26","author":"LT El-Saie","year":"2011","unstructured":"El-Saie LT, Rabie AR, Kamel MI, Seddeik AK, Elsaie ML. Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis. Lasers Med Sci. 2011;26:481\u20135.","journal-title":"Lasers Med Sci"},{"key":"854_CR102","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1001\/archdermatol.2011.1614","volume":"148","author":"KK Park","year":"2012","unstructured":"Park KK, Murase JE. Narrowband UV-B phototherapy during pregnancy and folic acid depletion. Arch Dermatol [Internet]. 2012;148:132\u20133. https:\/\/doi.org\/10.1001\/archdermatol.2011.1614.","journal-title":"Arch Dermatol [Internet]."},{"key":"854_CR103","first-page":"2925","volume":"125","author":"Y-G Yang","year":"2012","unstructured":"Yang Y-G, Zou X-B, Zhao H, Zhang Y-J, Li H-J. Photodynamic therapy of condyloma acuminata in pregnant women. Chin Med J (Engl). 2012;125:2925\u20138.","journal-title":"Chin Med J (Engl)"},{"key":"854_CR104","unstructured":"Cutera. AviClear Laser System [FDA Clearance] [Internet]. U.S. Food and Drug Administration; 2022. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K213461.pdf"},{"key":"854_CR105","first-page":"1","volume":"19","author":"R van der Graaf","year":"2018","unstructured":"van der Graaf R, van der Zande ISE, den Ruijter HM, Oudijk MA, van Delden JJM, Oude Rengerink K, et al. Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach. Trials. BioMed Central. 2018;19:1\u20139.","journal-title":"BioMed Central"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00854-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00854-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00854-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T19:05:39Z","timestamp":1673118339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00854-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["854"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00854-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}